The possible role of enteroviral persistence in the etiology of the chronic fatigue syndrome (CFS) was investigated by serological testing, VFM antigen testing, and polymerase chain reac tion (PCR) analysis of stool specimens as well as by viral cultures of stool-both direct and after acid treatment. No differences between 76 patients with disabling unexplained fatigue and 76 matched controls were found by serological or antigen testing. Furthermore, no enteroviruses were isolated from any stool culture. Enterovirus was detected by PCR in one stool specimen from a patient with CFS but was not detectable in a second sample obtained from the same patient 3 months later. All stool specimens from controls were PCR-ncgative. These results argue against the hypothesis that enteroviruses persist in patients with CFS and that their persis tence plays a role in the pathogenesis of this syndrome.
The chronic fatigue syndrome (CFS) is characterized by excessive fatigue o f at least 6 m onths' duration. Usually this fatigue is accom panied by a variety o f nonspecific symptoms, such as myalgia, im pairment o f memory, and difficulties in concentration. The disease leads to a dim inution o f physical and mental functioning.
The etiology o f CFS is not known. However, many pa tients with CFS believe that an infectious disease is the inciting event. Viruses that have been associated with CFS include Epstein-Barr virus, hum an herpesvirus 6, cytomega lovirus, retroviruses, and enteroviruses. O f the enteroviruses, the coxsackie B viruses have been considered particularly likely to be involved in CFS because o f their myotropic and neurotropic character.
Support for an etiologic role of enteroviruses in CFS is derived from studies in the United Kingdom [1] [2] [3] [4] [5] . Several investigators have found enterovirus in stool (by culture) [ 1 ] , in blood (by the VP-1 test) | I ], and in muscle (by slot-blot hybridization and the polymerase chain reaction [P C R ]) [2] [3] [4] . In addition, one group reported high levels of neutraliz ing antibodies to coxsackie B viruses [5J. On the basis of these results, it was suggested that the persistence ofenteroviruses plays a role in CFS [ 1, [3] [4] [5] . O ther studies, however, failed to confirm such a role [6] [7] [8] . In the latter studies, both antibodies to enteroviruses and VP-1 antigen were found with equal frequency in patients with CFS and in controls.
O ur aim in this study was to investigate the persistence of enteroviruses in a group o f patients with CFS and in a wellmatched control group. To this end, we performed enterovi rus-specific serological testing and VP-1 antigen testing on serum samples, and we subjected stool samples to PCR and viral culture (both direct and after acid treatm ent for the dissociation o f putative im m une complexes). This study was part o f a broader multidisciplinary investigation evaluating clinical, psychological, and laboratory data from patients with CFS.
Materials and Methods
Patients. Seventy-six patients and 76 healthy controls were examined. Patients were randomly chosen from a data base o f 298 patients with CFS. (This group, which was selfreferred. has been described in detail by Vercoulen et al. [9] .) All patients reported severe, unexplained, debilitating fa tigue o f at least I year's duration. The enrolled patients came to our outpatient clinic twice within a 3-month interval. On the second visit, each patient was accom panied by a neigh bor o f the same gender and within 2 years o f the same age; this control was selected by the patient. Patients and controls visited our clinic between Decem ber 1991 and April 1992 a period covering m onths during which the incidence of in fections due to enteroviruses is usually low in the Nether-■ / lands. Samples of blood and stool were obtained from patients and controls. All patients underwent a physical ex amination and an extensive laboratory work-up and com pleted a questionnaire that solicited information on age, sex. and duration and nature of symptoms.
Antibodv-capture ELISA. A broadly reactive antibodycapture ELISA was used for the detection o f IgG, IgM, and IgA antibodies to enteroviruses [10] . A strongly positive serum sample, a " cutoff' sample, and a negative control sam ple were included in each test. The cutoff value was based on the assumption that at most 5rc o f serum samples from 200 healthy blood donors would he reactive. Thus levels were scored as positive (greater than the cutoff value) only when they exceeded those in a healthy population. Serum samples from patients and controls were tested simultaneously in order to minimize the day-to-day variability o f the assay.
Complément-fixation test. The C F test was performed ac cording to the microtiter technique described by Casey [II] . The enteroviral antigen used in this test (Behringwerke AG. Marburg, G erm any) actually consisted o f a mixture of anti gens, including those o f coxsackieviruses B1 through B5; coxsackievirus A9; and echoviruses 4, 6, 9, 14, 24. and 30. The CF titer was expressed as the reciprocal o f the highest dilution showing 50% hemolysis. Serum samples from pa tients and controls were tested simultaneously.
VP-1 test. The VP-1 antigen test was performed at the laboratory o f Dr. J. F. Mowbray (D epartm ent o f Im m unopathology, St. M ary's Hospital Medical School, London). The enterovirus group-reactive m onoclonal antibody 5-D8/1 was used [12] . Serum samples from patients and controls were randomly num bered for blind test in«. The remaining 95-mL volume of supernatant was centri fuged in two bottles at 150,000 g for 3 hours. The supernatants were removed. One pellet was resuspended in 2.5 mL o f MEM with 3% FBS and stored at -70°C for acid elution. The other pellet was stored directly at -70°C for PCR. [ 15] , with use of an end-labeled oligonu cleotide probe (table 1) .
Isolation o f virus after acid elution. Acid elution was per formed as described by Y ousefet al. [ 1 ] with slight modifica tions. In brief, a 1.5-mL volume o f 0 . 1 A/glycine/HCl buffer (pH 2.4) was added to 2.5 mL o f concentrated stool extract, % and the pH was readjusted to 2.4 with 0.5 M HC1. The mix ture was incubated at room temperature for 3 hours and then centrifuged over a 30% sucrose cushion at pH 2.4 for 3 hours at 150,000 g. The pellet was resuspended in 2 mL of MEM with 3% FBS, and the pH was adjusted to 7.0 by the addition o f 0.5 M NaOH. The suspension was then inoculated in du plicate onto tertiary monkey kidney cells and human fetal lung fibroblasts (1 mL of concentrated stool extract plus 2.5 mL o f culture m edium) seeded in 25-cnr flasks (no. 690160; Greiner G m bH . Frickenhausen, Germany). After absorption for I hour at room temperature, the inoculum was decanted, and a 5-mL volume o f culture medium was added to the flasks, which were subsequently incubated at 37°C. The culNested PCR. Primers were selected from the 5' nontranstures were examined for CPE every 3 days for 6 weeks. Blind lated region, which is highly conserved am ong enteroviruses. The primers were 100% homologous to the known en teroviral RNA sequences. RNA was extracted from the concentrated fecal pellet by the acid guanidinium thiocyanate-phenol-chloroform procedure (RNAzol B method; Cinna/Biotecx Laboratories, Houston. Texas), as described by Chomczynski and Sacchi [ 14] .
Reverse transcription was performed essentially as de scribed by Zoll et al. [ 1 5] , with primer 4 as the reverse primer passages were done after 2 and 4 weeks.
Results
Demographic and clinical information. The mean age of the 76 patients was 40 years (median. 4 1 years; range. 20-66 years); the mean age o f the 76 controls was 41 years (median. 42 years; range. 19-67 years). T he male-to-female ratio for patients was 1:3. The majority of patients reported myalgia, and primer 1 as the sense primer (see table 1 ). The amplified muscular weakness, impairment o f memory, and problems CID 1994; 19 (November) Nested PCR. Nested PCR was used for the analysis of concentrated stool extracts from all 76 patients and all 76 controls. An amplification product was visualized by gel elec trophoresis in one sample from a patient with CFS and in no samples from controls; the single positive result was con firmed by Southern blot hybridization (figure 4). The patient for whom this result was obtained had a negative result in the VP-1 antigen test and in serological tests. No enteroviral RNA was detected in a second stool specimen obtained from this patient 3 m onths later.
Isolation o f virus from stool specimens. All direct cultures of stool for enteroviruses gave negative results. Acid elution with subsequent culture was undertaken for 23 patients and 22 controls who had either a high antibody titer (i.e., a titer higher than those o f 95% of healthy blood donors) or a posi tive result in the VP-1 antigen test; for the patient with a positive PCR result; and for a randomly selected group o f 22 o f the remaining 52 patients. The virological findings for these patients are presented in table 2. No virus was isolated.
Discussion
To investigate the possible role o f enteroviral persistence in CFS, we examined serum and stool specimens from 76 patients with CFS and 76 controls matched for gender, age, and neighborhood. (W e used neighborhood controls to correct for the potential effects o f local epidemics o f infec tion due to enteroviruses.) We found no differences between patients and controls in either the prevalence or the titer of enteroviral antibodies, whether assayed by the CF test or by an antibody-capture ELISA broadly reactive with different serotypes [ 10] . These results are in agreement with those of Miller et al. [8] , who found no difference between the IgM and IgG serum antibody titers o f patients with CFS and those o f controls. Like Lynch and Seth [6 ] and Halpin and Wessely |7j. we failed to find differences in the prevalence of VP-1 antigen in serum samples from patients and controls. These results are in contrast to those obtained by Yousef et al. [ 1 ] . who found VP-1 antigen in the serum of 44 o f 87 patients with postviral fatigue syndrom e (PVFS) but in no serum sam ples from controls. Enteroviral RNA was detected by PCR in a concentrated stool specimen from only one patient with CFS and in no such specimens from controls. A stool sample obtained 3 m onths later from the patient with a positive result was nega- tive for enteroviral RNA. Several research groups have shown that the limit of detection of enteroviruses in fecal samples by PCR is as low as I pfu [18, 19] . The sensitivity o f the PCR technique described by our group [ I 5] was found to be as low as 10 genome equivalents in a model system but was -20 pfu in biological samples. Use o f nested PCR in creased the sensitivity to <1 pfu [20, 21 ] After an acid dissociation step, Yousef et al. [1] isolated enteroviruses from stool specimens from 17 o f 76 patients with PVFS; these patients* direct cultures had been negative. % However, we isolated no enteroviruses from stool specimens from 46 selected patients and 22 selected controls by the same technique. Even the patient with a positive PCR result had a negative culture after acid elution. Thus, either the enterovirus involved in this infection is difficult to isolate in cell culture, or PCR is generally more sensitive than culture after acid elution. Consistent with a low incidence of entero viral infections in the winter, ali direct cultures were nega tive.
Several investigators have found enteroviral RNA se quences in muscle-biopsy specimens from patients w'ith PVFS [2] [3] [4] . In these studies PVFS was defined as severe fatigue starting after an acute episode o f an apparently viral illness and lasting for >1 year [1] [2] [3] [4] without laboratory evi dence of an initial infection as required by the definition of Sharpe et al. [ 1 7] . In cooperation with Drs. J. W. Gow and P. O. Behan (D epartm ent o f Neurology, Southern General Hospital, Glasgow, United Kingdom), we recently tested muscle-biopsy specimens from their patients with PVFS and from controls. We detected enteroviral RNA in several sam ples. However, the significance o f such findings is difficult to interpret since not only patients but also a num ber o f con trols had positive results ( [4] and authors' unpublished re sults). The discrepancy between the latter findings and those 864 Swanink et al. CID 1994; 19 (November) obtained in the study reported herein may be explained by epidemiological differences in viral incidence between the United Kingdom and the Netherlands. Alternatively, it may reflect differences in methods o f patient selection and in case definition. We used the case definition o fC F S on which consensus has been reached in the United Kingdom [ 1 7] ; this definition is different from that ofPV FS. Still, 66% of our patients re ported an acute onset o f their symptoms after an infectious illness and would qualify as having PVFS as defined by Yousef et al. [ 1 ] and Gow et al. [4] . The only difference between our patients and those in the studies from the United Kingr average duration o f illness in the former. It is unlikely that this difference accounts for the negative re sults obtained in our study, however, because there was a considerable overlap in the duration o f illness docum ented in the three studies. There was no correlation between the duration o f symptoms or the acuteness o f onset o f symptoms and the outcom e o f virological tests in our study. Gow et al. found no correlation between the duration o f PVFS and PCR positivity [4] . A similar discrepancy is apparent in the incidence o f enteroviruses in association with the inflamma tory myopathies polymyositis and dermatomyositis: investi gators in the United Kingdom have reported the persistence o f enteroviruses in patients with these conditions [3, 23. 24] , whereas researchers from other geographic areas (including our group in the Netherlands) have been unable to detect enteroviral RNA in muscle-biopsy specimens from these pa tients [25] [26] [27] .
In summary, we conclude that persistence o f enteroviruses is unlikely to play a role in the developm ent ofC FS.
